Loading...
SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia
Background: Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder resulting from exposure to dopamine receptor-blocking agents (DRBAs), such as antipsychotics. Valbenazine is a novel and highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor that is being...
Na minha lista:
| Udgivet i: | Schizophr Bull |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475908/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx023.016 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|